TTrialPathMatch Me to Trials
← Back to trials
RecruitingOsteoarthritis Shoulder

Diaphragm-Sparing Regional Anesthesia Techniques for Shoulder Surgery

Eligible age

65–100 yrs

Accepts

All genders

Locations

0 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This study will compare two regional anesthesia techniques for shoulder surgery and evaluate their effects on diaphragmatic function. The standard regional anesthesia technique for shoulder surgery is the interscalene brachial plexus block (ISB), which provides effective analgesia but is frequently associated with ipsilateral hemidiaphragmatic paresis due to phrenic nerve involvement. An alternative diaphragm-sparing strategy is the combination of a suprascapular nerve block (SSNB) and an infraclavicular brachial plexus block (ICB), which may reduce the risk of diaphragmatic dysfunction while maintaining effective analgesia for shoulder surgery. All participants will receive ultrasound-guided regional anesthesia prior to surgery and will be randomly assigned to one of two groups: Group 1: Interscalene brachial plexus block Group 2: Suprascapular nerve block combined with infraclavicular brachial plexus block The primary aim of this study is to determine whether the diaphragm-sparing technique reduces the incidence of hemidiaphragmatic paresis while providing analgesia comparable to the standard interscalene block. Diaphragmatic movement will be assessed using ultrasound before and after block placement. Secondary outcomes include postoperative pain intensity, opioid consumption, pulmonary function parameters, and block-related complications.

Sponsor: Poznan University of Medical Sciences

You may qualify if…

  • Age ≥ 65 years
  • Elective shoulder surgery
  • ASA I-III
  • Planned use of regional anesthesia
  • Signed written informed consent

You may not qualify if…

  • Allergy to local anesthetics
  • Planned continuous catheter technique
  • BMI \>40 kg/m²
  • Coagulopathy or anticoagulation
  • Pre-existing phrenic nerve palsy
  • Neurological disorder of the operative limb
  • Pregnancy or breastfeeding
  • Participation in another clinical trial within 30 days

Source: ClinicalTrials.gov · NCT07474896 · last updated 2026-05-22